<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00139399</url>
  </required_header>
  <id_info>
    <org_study_id>LREC 98-010</org_study_id>
    <nct_id>NCT00139399</nct_id>
  </id_info>
  <brief_title>Radial Artery Versus Saphenous Vein Patency (RSVP) Study</brief_title>
  <acronym>RSVP</acronym>
  <official_title>A Randomised Controlled Trial to Compare Angiographic Patency of Radial Artery Versus Saphenous Vein Used as Free Aorto-coronary Grafts in Coronary Revascularization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Royal College of Surgeons of England</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Heart Foundation, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Victor Phillip Dahdaleh Charitable Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the radial artery (artery in the arm) or
      saphenous vein (vein in the leg), when used as bypass grafts for coronary artery bypass
      surgery, have a greater patency rate (degree of opening)at 5 years after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arteries differ from veins both in morphology and physiology. Thus the way they behave as in
      vivo conduits when used in coronary artery bypass grafting is also likely to be different.
      This may partly explain the predisposition of veins used as coronary conduits to accelerated
      atherosclerosis in comparison with the internal mammary artery grafts. There are presently
      few data describing the properties of the radial artery as an in-vivo coronary conduit over
      the longer-term.

      The study will compare angiographic patency of the radial artery or saphenous vein graft
      anastomosed to the native left circumflex coronary territory at 3 months and 5 years after
      surgery. A substudy will compare 5-year post-surgery diameter and blood flow of in-vivo
      radial artery and saphenous vein grafts in response to endothelium-dependent and
      non-endothelium-dependent stimuli when patients attend for their scheduled follow-up
      angiogram.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 1998</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <primary_completion_date type="Actual">July 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patency Rates</measure>
    <time_frame>5 years</time_frame>
    <description>Angiographic patency rates of radial artery and long saphenous vein grafts at follow-up angiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean Diameter of the Study Graft (Saphenous Vein or Radial Artery)</measure>
    <time_frame>5 year follow-up</time_frame>
    <description>Diameter response of the study vessel (saphenous vein or radial artery graft) to acetylcholine, measured using quantitative coronary angiography from the coronary angiogram.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Flow Volume</measure>
    <time_frame>5 years</time_frame>
    <description>Graft flow response to acetylcholine, calculated from vessel diameter using quantitative coronary angiography, and velocity using an intragraft Doppler wire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">142</enrollment>
  <condition>Coronary Arteriosclerosis</condition>
  <arm_group>
    <arm_group_label>Saphenous vein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Saphenous vein aortocoronary bypass graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radial artery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radial artery aortocoronary bypass graft</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary artery bypass graft (CABG) surgery</intervention_name>
    <description>Patients were randomized to receive either a radial artery or a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery</description>
    <arm_group_label>Radial artery</arm_group_label>
    <arm_group_label>Saphenous vein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  on waiting list for clinically-indicated myocardial revascularization surgery

          -  aged 40-70 years

          -  significant stenosis (â‰¥70%) in the circumflex territory as identified on preoperative
             angiograms

          -  negative Allen's test (defined as the return of palmar circulation within 5 seconds of
             releasing ulnar artery compression)

          -  willing to give written informed consent

        Exclusion Criteria:

          -  poor left ventricular (LV) function (LV ejection fraction &lt;25%)

          -  severe diffuse peripheral vascular disease or bilateral varicose venous disease

          -  inability to comply with the angiographic follow-up at 3 months or/and 5 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil E Moat, MS, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royal Brompton &amp; Harefield NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Brompton &amp; Harefield NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SW3 6NP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Collins P, Webb CM, Chong CF, Moat NE; Radial Artery Versus Saphenous Vein Patency (RSVP) Trial Investigators. Radial artery versus saphenous vein patency randomized trial: five-year angiographic follow-up. Circulation. 2008 Jun 3;117(22):2859-64. doi: 10.1161/CIRCULATIONAHA.107.736215. Epub 2008 May 27.</citation>
    <PMID>18506009</PMID>
  </results_reference>
  <results_reference>
    <citation>Chong WC, Collins P, Webb CM, De Souza AC, Pepper JR, Hayward CS, Moat NE. Comparison of flow characteristics and vascular reactivity of radial artery and long saphenous vein grafts [NCT00139399]. J Cardiothorac Surg. 2006 Mar 3;1:4.</citation>
    <PMID>16722590</PMID>
  </results_reference>
  <results_reference>
    <citation>Webb CM, Moat NE, Chong CF, Collins P. Vascular reactivity and flow characteristics of radial artery and long saphenous vein coronary bypass grafts: a 5-year follow-up. Circulation. 2010 Aug 31;122(9):861-7. doi: 10.1161/CIRCULATIONAHA.109.887000. Epub 2010 Aug 16.</citation>
    <PMID>20713903</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>August 30, 2005</study_first_submitted>
  <study_first_submitted_qc>August 30, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2005</study_first_posted>
  <results_first_submitted>March 6, 2019</results_first_submitted>
  <results_first_submitted_qc>March 6, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 10, 2019</results_first_posted>
  <last_update_submitted>June 17, 2019</last_update_submitted>
  <last_update_submitted_qc>June 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary artery bypass</keyword>
  <keyword>Coronary arteries</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Angiography</keyword>
  <keyword>Blood flow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Saphenous Vein</title>
          <description>Saphenous vein aortocoronary bypass graft
Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during coronary artery bypass graft (CABG) surgery</description>
        </group>
        <group group_id="P2">
          <title>Radial Artery</title>
          <description>Radial artery aortocoronary bypass graft
Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during coronary artery bypass graft (CABG) surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Saphenous Vein</title>
          <description>Saphenous vein aortocoronary bypass graft
Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery</description>
        </group>
        <group group_id="B2">
          <title>Radial Artery</title>
          <description>Radial artery aortocoronary bypass graft
Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during CABG surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
            <count group_id="B2" value="82"/>
            <count group_id="B3" value="142"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="60"/>
                    <count group_id="B2" value="82"/>
                    <count group_id="B3" value="142"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="109"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="60"/>
                    <count group_id="B2" value="82"/>
                    <count group_id="B3" value="142"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="79"/>
                    <measurement group_id="B3" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patency Rates</title>
        <description>Angiographic patency rates of radial artery and long saphenous vein grafts at follow-up angiography</description>
        <time_frame>5 years</time_frame>
        <population>103 of the patients randomized at the time of surgery agreed to return for the 5-year follow-up angiogram.</population>
        <group_list>
          <group group_id="O1">
            <title>Saphenous Vein</title>
            <description>Saphenous vein aortocoronary bypass graft
Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery</description>
          </group>
          <group group_id="O2">
            <title>Radial Artery</title>
            <description>Radial artery aortocoronary bypass graft
Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during CABG surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Patency Rates</title>
          <description>Angiographic patency rates of radial artery and long saphenous vein grafts at follow-up angiography</description>
          <population>103 of the patients randomized at the time of surgery agreed to return for the 5-year follow-up angiogram.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Patent graft</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Occluded graft</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean Diameter of the Study Graft (Saphenous Vein or Radial Artery)</title>
        <description>Diameter response of the study vessel (saphenous vein or radial artery graft) to acetylcholine, measured using quantitative coronary angiography from the coronary angiogram.</description>
        <time_frame>5 year follow-up</time_frame>
        <population>Intracoronary physiology investigations (diameter and intracoronary Doppler blood flow velocity measurements) were carried out in a subgroup of patients (n=27).</population>
        <group_list>
          <group group_id="O1">
            <title>Saphenous Vein</title>
            <description>Saphenous vein aortocoronary bypass graft
Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery</description>
          </group>
          <group group_id="O2">
            <title>Radial Artery</title>
            <description>Radial artery aortocoronary bypass graft
Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during CABG surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Diameter of the Study Graft (Saphenous Vein or Radial Artery)</title>
          <description>Diameter response of the study vessel (saphenous vein or radial artery graft) to acetylcholine, measured using quantitative coronary angiography from the coronary angiogram.</description>
          <population>Intracoronary physiology investigations (diameter and intracoronary Doppler blood flow velocity measurements) were carried out in a subgroup of patients (n=27).</population>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.18" spread="0.67"/>
                    <measurement group_id="O2" value="2.7" spread="0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Flow Volume</title>
        <description>Graft flow response to acetylcholine, calculated from vessel diameter using quantitative coronary angiography, and velocity using an intragraft Doppler wire.</description>
        <time_frame>5 years</time_frame>
        <population>27 of the patients who returned for the 5 year angiogram were eligible for invasive measurement of blood flow.</population>
        <group_list>
          <group group_id="O1">
            <title>Saphenous Vein</title>
            <description>Saphenous vein aortocoronary bypass graft
Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery</description>
          </group>
          <group group_id="O2">
            <title>Radial Artery</title>
            <description>Radial artery aortocoronary bypass graft
Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during CABG surgery</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Flow Volume</title>
          <description>Graft flow response to acetylcholine, calculated from vessel diameter using quantitative coronary angiography, and velocity using an intragraft Doppler wire.</description>
          <population>27 of the patients who returned for the 5 year angiogram were eligible for invasive measurement of blood flow.</population>
          <units>ml/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39" spread="15"/>
                    <measurement group_id="O2" value="44" spread="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Saphenous Vein</title>
          <description>Saphenous vein aortocoronary bypass graft
Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery</description>
        </group>
        <group group_id="E2">
          <title>Radial Artery</title>
          <description>Radial artery aortocoronary bypass graft
Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during CABG surgery</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="82"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Percutaneous coronary intervention (PCI)/angio post surgery</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="60"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="82"/>
              </event>
              <event>
                <sub_title>Myocardial infarction (MI)</sub_title>
                <description>Heart attack</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Cerebrovascular accident (CVA)</sub_title>
                <description>Stroke</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="60"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Carolyn Webb</name_or_title>
      <organization>Imperial College London</organization>
      <phone>03301288860</phone>
      <email>c.webb@imperial.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

